Wednesday, July 8, 2026

Patent intelligence · US

US 11185600

Contrast agent and its use for imaging

granted A61KA61K49/0002A61K49/0034A61K49/0093
Status granted
Linked drugs 2
Pipeline programs 6
Years to expiry 15
Applicant portfolio 706
Patent details — US 11185600
Jurisdiction
US
Status
granted
Grant date
Nov 30, 2021
Expiration
Nov 25, 2041
Claims
13
CPC classes
A61K, A61K49/0002, A61K49/0034, A61K49/0093
View on Google Patents ↗

Quick answer

US 11185600 (Contrast agent and its use for imaging) is held by Stichting Radboud universitair medisch centrum. Status: granted. Granted Nov 30, 2021. Expires Nov 25, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Grant date
Expiration
Claims
13
CPC classes
A61K, A61K49/0002, A61K49/0034, A61K49/0093, A61K49/1818, A61K49/221

More from Stichting Radboud universitair medisch centrum

Related pharmaceutical patents in our USPTO index.

  1. US 12427173

    Use of bacteria, bacterial products, and other immunoregulatory entities in combination with anti-CTLA-4 and/or anti-PD-1 antibodies to treat solid tumor malignancies

    Biomed Valley Discoveries, Inc. · Expires Sep 25, 2045

    granted
  2. US 12428415

    Matriptase 2 inhibitors and uses thereof

    Disc Medicine, Inc. · Expires Sep 25, 2045

    granted
  3. US 12421236

    Seven-membered heterocyclic derivative acting as KRAS G12C mutant protein inhibitor

    Medshine Discovery Inc. · Expires Sep 18, 2045

    granted
  4. US 12420085

    Synergistic therapies for inter vertebral disc degeneration

    Discure Technologies Ltd · Expires Sep 18, 2045

    granted
  5. US 12421231

    Azaindole derivatives and their use as ERK kinase inhibitors

    AGV Discovery · Expires Sep 18, 2045

    granted
  6. US 12403069

    Adapter for use in a planetary mixer

    MEDISCA PHARMACEUTIQUE INC. · Expires Aug 28, 2045

    granted
  7. US 12398179

    Nanomolar peptides and derivatives to differentially modulate ephrin receptors

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Expires Aug 21, 2045

    granted
  8. US 12396924

    Adapter for use in a planetary mixer

    MEDISCA PHARMACEUTIQUE INC. · Expires Aug 21, 2045

    granted

Frequently asked questions

What is US patent 11185600?

US 11185600 (Contrast agent and its use for imaging) is held by Stichting Radboud universitair medisch centrum. Status: granted. Granted Nov 30, 2021. Expires Nov 25, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.

Who owns US 11185600?

Stichting Radboud universitair medisch centrum is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 706 pharmaceutical patents for this assignee.

When does US 11185600 expire?

Our index shows an expiration date of Nov 25, 2041 (15 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.